The promising results of a phase 1 clinical trial for the immunotherapy approach also showed that seven other women had no measurable disease at the end of the trial, the researchers added.
Their results are scheduled to be presented Saturday at the American Association for Cancer Research's annual meeting in Washington, D.C.
Ovarian cancer is fairly rare -- an estimated 1.38 percent of females born today will be diagnosed with the condition -- but it's an especially deadly form of cancer because it is usually diagnosed in an advanced stage.
The new treatment uses a personalized vaccine to try to teach the body's immune system how to fight off tumors.
The abortion rate is holding steady in the US despite total and partial bans in some...
A New Mexico jury determined Tuesday that Meta knowingly harmed children's mental health and concealed what...
A new COVID-19 variant, BA.3.2, has been detected in 25 states, according to a recent report...
A Georgia judge set a $1 bond for a woman facing murder charges tied to allegations...
